Last reviewed · How we verify
NCT07063303
Circadian Rhythm in Critical Illness
NA trial testing Intermittent feeding in Critical Illness in 24 participants. Completed in 29 September 2025.
29 September 2025
Quick facts
| Lead sponsor | Atılım University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 24 |
| Start date | 1 July 2025 |
| Primary completion | 29 September 2025 |
| Estimated completion | 29 September 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Intermittent feeding
- Continuous feeding
Conditions studied
- Critical Illness — all drugs for Critical Illness →
Sponsor
Atılım University
Who can join
18 and older, any sex, with Critical Illness. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to determine whether intermittent enteral feeding positively influences circadian rhythms in critically ill patients in intensive care units (ICUs). The main research questions are: 1. Does intermittent feeding improve circadian rhythms in ICU patients? 2. How does intermittent feeding affect metabolic markers and recovery outcomes? Researchers will compare intermittent feeding to continuous feeding, the current standard method, to assess its impact on circadian stability and patient health. Participants will: 1. Receive intermittent enteral feeding or continuous enteral feeding for at least 10 days 2. Undergo blood sample collection at three time points daily (morning, afternoon, midnight) to analyze circadian gene expression and metabolic markers 3. Have their clinical condition, nutrition status, and recovery progress monitored throughout the study
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07063303
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Critical Illness
Currently open trials in the same condition.
- NCT06189924 — Exhaled Breath Condensate Analysis in Mechanically Ventilated Patients · recruiting
- NCT07418242 — Prognostic Value of Novel Biomarkers on Adverse Renal Outcomes in High-Risk Cardiac Surgery Patients · recruiting
- NCT07101640 — PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary Dysp · Phase 1, PHASE2 · recruiting
- NCT07177183 — Low Serum Creatinine as a Predictor of Prolonged Mechanical Ventilation and Weaning Failure · NA · recruiting
- NCT07369258 — Clinical Application of Listening to Music to Prevent Delirium in the Intensive Care Unit · NA · recruiting
Other Atılım University trials
Trials by the same sponsor.
- NCT07105423 — Mindful Eating and Sustainability · recruiting
- NCT07103811 — Social Media Use, Food Craving and Ultra Processed Food Consumption in Students · recruiting
- NCT07269600 — Effects of Sarcopenia on Proprioception, Kinesiophobia, and Pressure Pain Threshold · active not recruiting
- NCT07131891 — The Effects of Electronic Cigarette and Traditional Cigarette · completed
- NCT07126899 — Hand Tendon Injuries: An Investigation Of Attention Deficit Disorder · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07063303 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Atılım University
- Last refreshed: 3 October 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07063303.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing